GSI 510 Pill - green capsule/oblong, 19mm
Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide
Pill with imprint GSI 510 is Green, Capsule/Oblong and has been identified as Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg. It is supplied by Gilead Sciences, Inc.
Genvoya is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 510


Genvoya
- Generic Name
- cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide
- Imprint
- GSI 510
- Strength
- cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
- Color
- Green
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
sodium lauryl sulfate,
croscarmellose sodium,
water,
magnesium stearate,
titanium dioxide,
magnesium silicate,
FD&C Blue No. 2,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
61958-1901 | Gilead Sciences, Inc. |
54569-6633 | A-S Medication Solutions, LLC (repackager) |
Related images for "GSI 510"
More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (129)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
Patient resources
Professional resources
- Genvoya prescribing information
- Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (AHFS Monograph)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.